FGEN
Price
$5.61
Change
+$0.36 (+6.86%)
Updated
Jul 3 closing price
Capitalization
22.67M
36 days until earnings call
MGNX
Price
$1.46
Change
+$0.08 (+5.80%)
Updated
Jul 3 closing price
Capitalization
92.11M
37 days until earnings call
Interact to see
Advertisement

FGEN vs MGNX

Header iconFGEN vs MGNX Comparison
Open Charts FGEN vs MGNXBanner chart's image
FibroGen
Price$5.61
Change+$0.36 (+6.86%)
Volume$33.07K
Capitalization22.67M
MacroGenics
Price$1.46
Change+$0.08 (+5.80%)
Volume$699.98K
Capitalization92.11M
FGEN vs MGNX Comparison Chart in %
Loading...
FGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FGEN vs. MGNX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FGEN is a Hold and MGNX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (FGEN: $5.61 vs. MGNX: $1.46)
Brand notoriety: FGEN and MGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FGEN: 81% vs. MGNX: 51%
Market capitalization -- FGEN: $22.67M vs. MGNX: $92.11M
FGEN [@Biotechnology] is valued at $22.67M. MGNX’s [@Biotechnology] market capitalization is $92.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FGEN’s FA Score shows that 0 FA rating(s) are green whileMGNX’s FA Score has 0 green FA rating(s).

  • FGEN’s FA Score: 0 green, 5 red.
  • MGNX’s FA Score: 0 green, 5 red.
According to our system of comparison, both FGEN and MGNX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FGEN’s TA Score shows that 5 TA indicator(s) are bullish while MGNX’s TA Score has 5 bullish TA indicator(s).

  • FGEN’s TA Score: 5 bullish, 5 bearish.
  • MGNX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both FGEN and MGNX are a good buy in the short-term.

Price Growth

FGEN (@Biotechnology) experienced а +5.85% price change this week, while MGNX (@Biotechnology) price change was +14.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

FGEN is expected to report earnings on Aug 11, 2025.

MGNX is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MGNX($92.1M) has a higher market cap than FGEN($22.7M). MGNX (-55.077) and FGEN (-57.620) have similar YTD gains . MGNX has higher annual earnings (EBITDA): -47.33M vs. FGEN (-110.48M). MGNX has more cash in the bank: 154M vs. FGEN (1.73M). MGNX has less debt than FGEN: MGNX (37.5M) vs FGEN (73.4M). MGNX has higher revenues than FGEN: MGNX (152M) vs FGEN (7M).
FGENMGNXFGEN / MGNX
Capitalization22.7M92.1M25%
EBITDA-110.48M-47.33M233%
Gain YTD-57.620-55.077105%
P/E RatioN/AN/A-
Revenue7M152M5%
Total Cash1.73M154M1%
Total Debt73.4M37.5M196%
FUNDAMENTALS RATINGS
FGEN vs MGNX: Fundamental Ratings
FGEN
MGNX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
80
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
9364
P/E GROWTH RATING
1..100
5695
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MGNX's Valuation (80) in the Biotechnology industry is in the same range as FGEN (93). This means that MGNX’s stock grew similarly to FGEN’s over the last 12 months.

MGNX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as FGEN (100). This means that MGNX’s stock grew similarly to FGEN’s over the last 12 months.

MGNX's SMR Rating (97) in the Biotechnology industry is in the same range as FGEN (100). This means that MGNX’s stock grew similarly to FGEN’s over the last 12 months.

MGNX's Price Growth Rating (64) in the Biotechnology industry is in the same range as FGEN (93). This means that MGNX’s stock grew similarly to FGEN’s over the last 12 months.

FGEN's P/E Growth Rating (56) in the Biotechnology industry is somewhat better than the same rating for MGNX (95). This means that FGEN’s stock grew somewhat faster than MGNX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FGENMGNX
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
85%
Momentum
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
81%
MACD
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
85%
Advances
ODDS (%)
Bullish Trend 12 days ago
86%
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 10 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
FGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BKSY21.481.21
+5.97%
BlackSky Technology Inc
HEPS2.800.06
+2.19%
D-Market Electronic Services & Trading
GPI466.001.38
+0.30%
Group 1 Automotive
KR69.83-0.40
-0.57%
Kroger Co (The)
GVH0.08-0.01
-7.80%
Globavend Holdings Limited

FGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, FGEN has been loosely correlated with AVTX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if FGEN jumps, then AVTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FGEN
1D Price
Change %
FGEN100%
+6.86%
AVTX - FGEN
57%
Loosely correlated
+0.40%
MGNX - FGEN
44%
Loosely correlated
+5.80%
AXON - FGEN
43%
Loosely correlated
+2.70%
BMRN - FGEN
41%
Loosely correlated
+0.58%
INSM - FGEN
39%
Loosely correlated
N/A
More

MGNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGNX has been loosely correlated with CRBU. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if MGNX jumps, then CRBU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGNX
1D Price
Change %
MGNX100%
+5.80%
CRBU - MGNX
51%
Loosely correlated
N/A
XNCR - MGNX
50%
Loosely correlated
+1.45%
BEAM - MGNX
47%
Loosely correlated
+0.65%
SYRE - MGNX
46%
Loosely correlated
+1.68%
RGNX - MGNX
46%
Loosely correlated
+1.39%
More